Skip to main content
Have a personal or library account? Click to login
Inflammation as a Cornerstone in the Early Diagnosis and Treatment of Pulmonary Embolism Cover

References

  1. Kaptein FHJ, Kroft LJM, Been HD, et al. Pulmonary infarction in acute pulmonary embolism. Thromb Res. 2021;202:162-9. doi: 10.1016/j.thromres.2021.03.022
  2. Wendelboe AM, Raskob GE. Global burden of thrombosis. Circ Res. 2016;118(9):1340-7. doi: 10.1161/CIRCRESAHA.115.306841
  3. Raskob GE, Angchaisuksiri P, Blanco AN, et al. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34(11):2363-71. doi: 10.1161/ATVBAHA.114.304488
  4. Cavallino C, Melillo F, Bonaventura A, et al. Novel challenges and therapeutic options for pulmonary embolism and deep vein thrombosis. J Pers Med. 2024;14(8):885. doi: 10.3390/jpm14080885
  5. Corrigan D, Prucnal C, Kabrhel C. Pulmonary embolism: the diagnosis, risk–stratification, treatment and disposition of emergency department patients. Clin Exp Emerg Med. 2016;3(3):117-25. doi: 10.15441/ceem.16.146
  6. Turetz M, Sideris A, Friedman O, Tripathi N, Horowitz J. Epidemiology, pathophysiology, and natural history of pulmonary embolism. Semin Intervent Radiol. 2018;35(2):92-8. doi: 10.1055/s-0038-1642036
  7. Righini M, Robert-Ebadi H, Le Gal G. Diagnosis of acute pulmonary embolism. J Thromb Haemost. 2017;15(7):1251-61. doi: 10.1111/jth.13694
  8. Ghaye B, Szapiro D, Mastora I, et al. Peripheral pulmonary arteries: how far in the lung does multi-detector row spiral CT allow analysis? Radiology. 2001;219(3):629-36. doi: 10.1148/radiology.219.3.r01jn32629
  9. Franchini M, Focosi D, Pezzo MP, Mannucci PM. How we manage a high D-dimer. Haematologica. 2023;108(10):2660-9. doi: 10.3324/haematol.2023.283966
  10. Bobescu E, Marceanu G, Dima L, et al. Trimetazidine therapy in coronary artery disease: the impact on oxidative stress, inflammation, endothelial dysfunction, and longterm prognosis. Am J Ther. 2021;28(5):e540-7. doi: 10.1097/MJT.0000000000001430
  11. Williams JS, Lutfy L, Silver J, et al. Differences in cardiovascular risk factors associated with sex and gender identity, but not gender expression, in young, healthy cisgender adults. Front Cardiovasc Med. 2024;11:1374765. doi: 10.3389/fcvm.2024.1374765
  12. Sánchez A, Mirabel JL, Barrenechea E, et al. Evaluation of an improved immunoturbidimetric assay for serum C-reactive protein on a COBAS INTEGRA 400 analyzer. Clin Lab. 2002;48(5-6):313-7.
  13. Mackie I, Casini A, Pieters M, et al. International Council for Standardisation in Haematology recommendations on fibrinogen assays, thrombin clotting time, and related tests in the investigation of bleeding disorders. Int J Lab Hematol. 2024;46(1):20-32. doi: 10.1111/ijlh.14201
  14. Louka M, Kaliviotis E. Development of an optical method for the evaluation of whole blood coagulation. Biosensors. 2021;11(4):113. doi: 10.3390/bios11040113
  15. Busceti MT, Sirignano P, D’Armiento FP, et al. Pulmonary embolism, metalloproteinases, and neutrophil gelatinase–associated lipocalin. Acta Phlebologica. 2013;14(3):115-21.
  16. Iba T, Levy JH. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. Trends Cardiovasc Med. 2022;32(5):249-56. doi: 10.1016/j.tcm.2022.02.008
  17. Elsheikh S, Lip GYH. Editorial commentary: COVID-19 and COVID-19 vaccination: observations on thrombosis and thrombocytopenia. Trends Cardiovasc Med. 2022;32(5):257-8. doi: 10.1016/j.tcm.2022.03.002
  18. Elalamy I, Gerotziafas G, Alamowitch S, et al. SARS-CoV-2 vaccine and thrombosis: an expert consensus on vaccine induced immune thrombotic thrombocytopenia. Thromb Haemost. 2021;121(8):982-91. doi: 10.1055/a-1499-0119
  19. Ageno W, Cohen AT, Hunt BJ, et al. Characteristics and management of patients with venous thromboembolism: the GARFIELD-VTE registry. TH Open. 2019;3(2):e319-27. doi: 10.1055/s-0038-1676611
  20. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet. 1999;353(9162):1386-9. doi: 10.1016/S0140-6736(98)07534-5
  21. Nakamura M, Fujioka H, Yamada N, et al. Clinical characteristics of acute pulmonary thromboembolism in Japan: results of a multicenter registry in the Japanese Society of Pulmonary Embolism Research. Clin Cardiol. 2001;24(2):132-8. doi: 10.1002/clc.4960240207
  22. Shah SMA, Khan RA, Ali A, et al. Risk management strategies and therapeutic modalities to tackle COVID-19/SARS-CoV-2. J Infect Public Health. 2021;14(3):331-46. doi: 10.1016/j.jiph.2020.12.023
  23. Haba SC, Nechita A, Iancu A, et al. The prognostic value of inflammatory indices in acute pulmonary embolism. Diagnostics. 2025;15(3):312. doi: 10.3390/diagnostics15030312
  24. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162(10):975-82. doi: 10.1093/aje/kwi309
  25. Piazza G, Goldhaber SZ. Venous thromboembolism and atherothrombosis: an integrated approach. Circulation. 2010;121(19):2146-50. doi: 10.1161/CIRCULATIONAHA.110.951236
  26. Anderson FA, Wheeler HB, Goldberg RJ, et al. A populationbased perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism: the Worcester DVT Study. Arch Intern Med. 1991;151(5):933-8. doi: 10.1001/archinte.1991.00400050065009
  27. Fauvel C, Weizman O, Trimaille A, et al. Pulmonary embolism in COVID-19 patients: a French multicentre cohort study. Eur Heart J. 2020;41(32):3058-68. doi: 10.1093/eurheartj/ehaa500
  28. Kruse L, Mitchell AM, Camargo CA, Hernandez J, Kline JA. Frequency of thrombophilia-related genetic variations in patients with idiopathic pulmonary embolism in an urban emergency department. Clin Chem. 2006;52(6):1026-32. doi: 10.1373/clinchem.2005.061861
  29. Tuzovic M, Herrmann J, Iliescu C, et al. Arterial thrombosis in patients with cancer. Curr Treat Options Cardiovasc Med. 2018;20(5):40. doi: 10.1007/s11936-018-0635-x
  30. Kawano K, Koide M, Nakatani K, et al. Shear-induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis. Clin Cardiol. 2002;25(4):154-60. doi: 10.1002/clc.4960250405
  31. Connolly GC, Francis CW. Cancer-associated thrombosis. Hematology Am Soc Hematol Educ Program. 2013;2013(1):684-91. doi: 10.1182/asheducation-2013.1.684
  32. Naess IA, Christiansen SC, Romunstad P, et al. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692-9. doi: 10.1111/j.1538-7836.2007.02450.x
  33. Messmore H, Wehrmacher WH. Book review: Coagulation in cancer. Clin Appl Thromb Hemost. 2009;15(6):714. doi: 10.1177/1076029609344589
  34. Hottz ED, Azevedo-Quintanilha IG, Palhinha L, et al. Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19. Blood. 2020;136(11):1330-41. doi: 10.1182/blood.2020007252
  35. Nuche S, Pérez-Olivares C, Arroyo D, et al. Effect of coronavirus disease 2019 in pulmonary circulation: the particular scenario of precapillary pulmonary hypertension. Diagnostics. 2020;10(8):548. doi: 10.3390/diagnostics10080548
  36. Becker RC. COVID-19 update: COVID-19-associated coagulopathy. J Thromb Thrombolysis. 2020;50(1):54-67. doi: 10.1007/s11239-020-02134-3
  37. Nauka PC, Oran E, Chekuri S. Deep venous thrombosis in a non–critically ill patient with novel COVID-19 infection. Thromb Res. 2020;192:27-8. doi: 10.1016/j.thromres.2020.05.015
  38. Poissy J, Goutay J, Caplan M, et al. Pulmonary embolism in patients with COVID-19. Circulation. 2020;142(2):184-6. doi: 10.1161/CIRCULATIONAHA.120.047430
  39. Cui S, Chen X, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemost. 2020;18(6):1421-4. doi: 10.1111/jth.14830
  40. Blokhin IO, Lentz SR. Mechanisms of thrombosis in obesity. Curr Opin Hematol. 2013;20(5):437-44. doi: 10.1097/MOH.0b013e3283634443
  41. Lentz SR. Thrombosis in the setting of obesity or inflammatory bowel disease. Blood. 2016;128(20):2388-94. doi: 10.1182/blood-2016-05-716720
  42. Liu X, Xu D, Li H, et al. Prevalence, risk factors, and clinical characteristics of venous thrombus embolism in patients with acute exacerbation of COPD: a prospective multicenter study. Int J Chron Obstruct Pulmon Dis. 2023;18:907-17. doi: 10.2147/COPD.S410954
  43. Ng TMH, Tsai F, Khatri N, Barakat MN, Elkayam U. Venous thromboembolism in hospitalized patients with heart failure. Circ Heart Fail. 2010;3(1):165-73. doi: 10.1161/CIRCHEARTFAILURE.109.892349
  44. Xu P, Luo L, Liu J, et al. Heart failure is associated with increased risk of long-term venous thromboembolism. Korean Circ J. 2021;51(9):766-76. doi: 10.4070/kcj.2021.0213
  45. Miniati M, Cenci S, Monti S, Poli D. Clinical presentation of acute pulmonary embolism: survey of 800 cases. PLoS One. 2012;7(2):e30891. doi: 10.1371/journal.pone.0030891
  46. Chatterjee S, Chakraborty A, Weinberg I, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA. 2014;311(23):2414-21. doi: 10.1001/jama.2014.5990
  47. Marti C, John G, Konstantinides S, et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis. Eur Heart J. 2015;36(10):605-14. doi: 10.1093/eurheartj/ehu218
  48. Amini S, Bakhshandeh H, Mosaed R, et al. Efficacy and safety of different dosages of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: a systematic review and meta-analysis. Iran J Pharm Res. 2021;20(2):441-54. doi: 10.22037/ijpr.2021.114142.14688
  49. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Respir J. 2019;54(3):1901647. doi: 10.1183/13993003.01647-2019
  50. Stein PD, Woodard PK, Weg JG, et al. Clinical characteristics of patients with acute pulmonary embolism: data from PIOPED II. Am J Med. 2007;120(10):871-9. doi: 10.1016/j.amjmed.2007.03.024
  51. den Exter PL, Zondag W, Klok FA, et al. Efficacy and safety of outpatient treatment based on the Hestia clinical decision rule with or without N-terminal pro-brain natriuretic peptide testing in patients with acute pulmonary embolism: a randomized clinical trial. Am J Respir Crit Care Med. 2016;194(8):998-1006. doi: 10.1164/rccm.201512-2494OC
  52. Platz E, Goldhaber SZ, Neilan TG, et al. Regional right ventricular strain pattern in patients with acute pulmonary embolism. Echocardiography. 2012;29(4):464-70. doi: 10.1111/j.1540-8175.2011.01617.x
  53. Sugiura S, Takahashi S, Omura M, et al. Reversible right ventricular regional non-uniformity quantified by speckletracking strain imaging in patients with acute pulmonary thromboembolism. J Am Soc Echocardiogr. 2009;22(12):1353-9. doi: 10.1016/j.echo.2009.08.02
DOI: https://doi.org/10.2478/jce-2025-0017 | Journal eISSN: 2457-5518 | Journal ISSN: 2457-550X
Language: English
Page range: 68 - 78
Submitted on: Jul 28, 2025
Accepted on: Aug 29, 2025
Published on: Jun 24, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Alexandru Covaciu, Emanuel Cojocariu, Elena Bobescu, Valentina Benza, Nicoleta Cojocaru, Georgiana Laura Stefănescu, Madalina Ivascu, Lilia Aida Mahjoub, Andreea Amalia Tomulescu, Christian Gabriel Strempel, Horatiu Rus, published by Asociatia Transilvana de Terapie Transvasculara si Transplant KARDIOMED
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.